NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia

Samankaltaisia teoksia

• The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL–BFM 2000 protocol can be separated from FBXW7 loss of function
  Tekijä: Kox, C, et al.
  Julkaistu: (2010)
• High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
  Tekijä: Cario, Gunnar, et al.
  Julkaistu: (2014)
• IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
  Tekijä: Dörge, Petra, et al.
  Julkaistu: (2013)
• NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia
  Tekijä: Hof, Jana, et al.
  Julkaistu: (2017)
• Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy
  Tekijä: Stanulla, Martin, et al.
  Julkaistu: (2001)